Orchestra BioMed
OBIO
OBIO
42 hedge funds and large institutions have $114M invested in Orchestra BioMed in 2023 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 23 increasing their positions, 5 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
6.48% more ownership
Funds ownership: 30.16% → 36.64% (+6.5%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
42
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$9.19M | |
| 2 | +$4.14M | |
| 3 | +$3.31M | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.93M |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$774K |
Top Sellers
| 1 | -$453K | |
| 2 | -$378K | |
| 3 | -$199K | |
| 4 |
Swiss National Bank
Zurich,
Switzerland
|
-$193K |
| 5 |
BC
Boxer Capital
San Diego,
California
|
-$103K |